Why does a drug trial take years, and what does each phase actually prove?

In the latest Synapse Session, Alterity CEO Dr David Stamler talks with Professor Daniel Claassen, Professor of Neurology at Vanderbilt University Medical Center and Alterity's Chief Medical Advisor, about how clinical trials work. They cover what Phase 1, 2 and 3 are each designed to answer.

They then turn to ATH434 in Multiple System Atrophy (MSA), including what was learned from the Phase 2 study and what comes next as the program moves toward Phase 3.